Azenta, Inc. · NASDAQ:AZTA

Azenta — Brooks Automation — Merger or Acquisition (September 2021)

11 slides from Azenta's merger presentation, Sep 21, 2021

  1. Slide 1: Conference Call: Divestiture of Brooks Semiconductor Solutions Group Business

    Brooks Automation Conference Call: Divestiture of Brooks Semiconductor Solutions Group Business September 20, 2021 Exhibit 99.2

  2. Slide 2: Safe Harbor Statement

    © 2021 Brooks Automation, Inc. • Proprietary Information Safe Harbor Statement “Safe Harbor” Statement under the U.S. Private Securities Litigation Reform Act of 1995; certain matters in this presentation, including forecasts of future demand and future Company performance, are forward-looking state

  3. Slide 3: Compelling Strategic Rationale

    © 2021 Brooks Automation, Inc. • Proprietary Information Compelling Strategic Rationale ▪ Brooks has entered into a definitive agreement to sell the semiconductor automation business to Thomas H. Lee Partners (“THL”) ▪ The sale is the result of a rigorous process run by management and the Board ▪ Br

  4. Slide 4: Transaction Highlights, Financial Impact and Timing

    © 2021 Brooks Automation, Inc. • Proprietary Information ▪ Selling semiconductor automation business, consisting of Brooks’ Semiconductor Solutions Group (BSSG) segment, to THL for $3.0B in cash ▪ Approximately 5x LTM Revenue and 19x LTM EBITDA ▪ Expected after-tax cash proceeds of approximately $2.

  5. Slide 5: Strong Track Record of Continuous Portfolio Enhancement

    © 2021 Brooks Automation, Inc. • Proprietary Information Strong Track Record of Continuous Portfolio Enhancement: Positioning Life Sciences with Fuel for Accelerated Growth • RTS for $3M • Nexus for $85M • Crossing Automation for $59M • Divested of Contract Manufacturing for $78M • FluidX for $16M •

  6. Slide 6: Standalone Life Sciences Co: Strong Organic Growth Supported by Acquisitions

    © 2021 Brooks Automation, Inc. • Proprietary Information Note: $ in millions; figures indicate life sciences revenue fiscal years ending 9/30; 2021E represents midpoint of management guidance Standalone Life Sciences Co Strong Organic Growth Supported by Acquisitions $11 $53 $43 $63 $68 $108 $149 $1

  7. Slide 7: Unique Value Proposition: All the Building Blocks in Place

    © 2021 Brooks Automation, Inc. • Proprietary Information Unique Value Proposition Size Profitability and Cash Flow Capital to Deploy Leadership >$500M run-rate revenue as a standalone business Differentiated portfolio addressing high-growth markets Solidly positive and growing operating margin with

  8. Slide 8: Today's Announcement – What to Expect

    © 2021 Brooks Automation, Inc. • Proprietary Information Today’s Announcement – What to Expect 8 Standalone Life Sciences Co ▪ Timing: ▪ Sale expected to complete in first half of calendar year 2022 ▪ Branding Transition: ▪ The Brooks Automation name and branding will transfer along with the semicon

  9. Slide 9: Key Takeaways

    © 2021 Brooks Automation, Inc. • Proprietary Information Key Takeaways 1. Sale of the Semiconductor Automation business for $3B, ~19x LTM EBITDA 2. Life Sciences business to operate as a standalone publicly traded company 3. Cash proceeds to enable continued significant strategic investments 4. A un

  10. Slide 10: Appendix

    Appendix 10

  11. Slide 11: Reconciliation to Adjusted EBITDA

    © 2021 Brooks Automation, Inc. • Proprietary Information Reported Standalone Standalone LTM Jun-21 Adjustments LTM Jun-21 Operating Profit 125 8 133 Adjustments: Non-operating expenses - (0) (0) Depreciation 5 1 6 Amortization of intangible assets 3 2 4 EBITDA 132 11 143 EBITDA margin 21.5% 23.3% Pu

Brooks Automation — Merger or Acquisition (September 2021) on 6ix